Cargando…

MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency

BACKGROUND: Binding of the viral envelope protein (Env), and particularly of its gp120 subunit, to the cellular CD4 receptor is the first essential step of the HIV-1 entry process. The CD4 binding site (CD4bs) of gp120, and especially a recessed cavity occupied by the CD4 Phe43 residue, are known to...

Descripción completa

Detalles Bibliográficos
Autores principales: Grupping, Katrijn, Selhorst, Philippe, Michiels, Johan, Vereecken, Katleen, Heyndrickx, Leo, Kessler, Pascal, Vanham, Guido, Martin, Loïc, Ariën, Kevin K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408336/
https://www.ncbi.nlm.nih.gov/pubmed/22551420
http://dx.doi.org/10.1186/1742-4690-9-36
_version_ 1782239438825324544
author Grupping, Katrijn
Selhorst, Philippe
Michiels, Johan
Vereecken, Katleen
Heyndrickx, Leo
Kessler, Pascal
Vanham, Guido
Martin, Loïc
Ariën, Kevin K
author_facet Grupping, Katrijn
Selhorst, Philippe
Michiels, Johan
Vereecken, Katleen
Heyndrickx, Leo
Kessler, Pascal
Vanham, Guido
Martin, Loïc
Ariën, Kevin K
author_sort Grupping, Katrijn
collection PubMed
description BACKGROUND: Binding of the viral envelope protein (Env), and particularly of its gp120 subunit, to the cellular CD4 receptor is the first essential step of the HIV-1 entry process. The CD4 binding site (CD4bs) of gp120, and especially a recessed cavity occupied by the CD4 Phe43 residue, are known to be highly conserved among the different circulating subtypes and therefore constitute particularly interesting targets for vaccine and drug design. The miniCD4 proteins are a promising class of CD4bs inhibitors. Studying virus evolution under pressure of CD4bs inhibitors could provide insight on the gp120-CD4 interaction and viral entry. RESULTS: The present study reports on the resistance induction of two subtype B HIV-1 against the most active miniCD4, M48U1, and its ancestor, M48, and how these mutated positions affect CD4bs recognition, entry efficiency, and sensitivity to other CD4bs inhibitors. Resistance against M48U1 was always associated with S375R/N substitution in both BaL and SF162; M48 resistance was associated with D474N substitution in SF162 and with H105Y substitution in BaL. In addition, some other mutations at position V255 and G471 were of importance for SF162 resistant viruses. Except for 474, all of these mutated positions are conserved, and introducing them into an SF162 Env expressing infectious molecular clone (pBRNL4.3 SF162) resulted in decreased entry efficiency. Furthermore, resistant mutants showed at least some cross-resistance towards other CD4bs inhibitors, the V3 monoclonal antibody 447-52D and some even against the monoclonal antibody 17b, of which the epitope overlaps the co-receptor binding site. CONCLUSIONS: The mutations H105Y, V255M, S375R/N, G471R/E, and D474N are found to be involved in resistance towards M48 and M48U1. All mutated positions are part of, or in close proximity to, the CD4bs; most are highly conserved, and all have an impact on the entry efficiency, suggesting their importance for optimal virus infectivity.
format Online
Article
Text
id pubmed-3408336
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34083362012-07-31 MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency Grupping, Katrijn Selhorst, Philippe Michiels, Johan Vereecken, Katleen Heyndrickx, Leo Kessler, Pascal Vanham, Guido Martin, Loïc Ariën, Kevin K Retrovirology Research BACKGROUND: Binding of the viral envelope protein (Env), and particularly of its gp120 subunit, to the cellular CD4 receptor is the first essential step of the HIV-1 entry process. The CD4 binding site (CD4bs) of gp120, and especially a recessed cavity occupied by the CD4 Phe43 residue, are known to be highly conserved among the different circulating subtypes and therefore constitute particularly interesting targets for vaccine and drug design. The miniCD4 proteins are a promising class of CD4bs inhibitors. Studying virus evolution under pressure of CD4bs inhibitors could provide insight on the gp120-CD4 interaction and viral entry. RESULTS: The present study reports on the resistance induction of two subtype B HIV-1 against the most active miniCD4, M48U1, and its ancestor, M48, and how these mutated positions affect CD4bs recognition, entry efficiency, and sensitivity to other CD4bs inhibitors. Resistance against M48U1 was always associated with S375R/N substitution in both BaL and SF162; M48 resistance was associated with D474N substitution in SF162 and with H105Y substitution in BaL. In addition, some other mutations at position V255 and G471 were of importance for SF162 resistant viruses. Except for 474, all of these mutated positions are conserved, and introducing them into an SF162 Env expressing infectious molecular clone (pBRNL4.3 SF162) resulted in decreased entry efficiency. Furthermore, resistant mutants showed at least some cross-resistance towards other CD4bs inhibitors, the V3 monoclonal antibody 447-52D and some even against the monoclonal antibody 17b, of which the epitope overlaps the co-receptor binding site. CONCLUSIONS: The mutations H105Y, V255M, S375R/N, G471R/E, and D474N are found to be involved in resistance towards M48 and M48U1. All mutated positions are part of, or in close proximity to, the CD4bs; most are highly conserved, and all have an impact on the entry efficiency, suggesting their importance for optimal virus infectivity. BioMed Central 2012-05-02 /pmc/articles/PMC3408336/ /pubmed/22551420 http://dx.doi.org/10.1186/1742-4690-9-36 Text en Copyright ©2012 Grupping et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Grupping, Katrijn
Selhorst, Philippe
Michiels, Johan
Vereecken, Katleen
Heyndrickx, Leo
Kessler, Pascal
Vanham, Guido
Martin, Loïc
Ariën, Kevin K
MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency
title MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency
title_full MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency
title_fullStr MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency
title_full_unstemmed MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency
title_short MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency
title_sort minicd4 protein resistance mutations affect binding to the hiv-1 gp120 cd4 binding site and decrease entry efficiency
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408336/
https://www.ncbi.nlm.nih.gov/pubmed/22551420
http://dx.doi.org/10.1186/1742-4690-9-36
work_keys_str_mv AT gruppingkatrijn minicd4proteinresistancemutationsaffectbindingtothehiv1gp120cd4bindingsiteanddecreaseentryefficiency
AT selhorstphilippe minicd4proteinresistancemutationsaffectbindingtothehiv1gp120cd4bindingsiteanddecreaseentryefficiency
AT michielsjohan minicd4proteinresistancemutationsaffectbindingtothehiv1gp120cd4bindingsiteanddecreaseentryefficiency
AT vereeckenkatleen minicd4proteinresistancemutationsaffectbindingtothehiv1gp120cd4bindingsiteanddecreaseentryefficiency
AT heyndrickxleo minicd4proteinresistancemutationsaffectbindingtothehiv1gp120cd4bindingsiteanddecreaseentryefficiency
AT kesslerpascal minicd4proteinresistancemutationsaffectbindingtothehiv1gp120cd4bindingsiteanddecreaseentryefficiency
AT vanhamguido minicd4proteinresistancemutationsaffectbindingtothehiv1gp120cd4bindingsiteanddecreaseentryefficiency
AT martinloic minicd4proteinresistancemutationsaffectbindingtothehiv1gp120cd4bindingsiteanddecreaseentryefficiency
AT arienkevink minicd4proteinresistancemutationsaffectbindingtothehiv1gp120cd4bindingsiteanddecreaseentryefficiency